世界のガン・ヤヌス・キナーゼ抑制剤市場:販売動向2019

QYResearchが発行した調査報告書(DATA907A1782)
◆英語タイトル:Global Cancer Janus Kinase Inhibitors Sales Market Report 2019
◆商品コード:DATA907A1782
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年8月(※2024年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ガン・ヤヌス・キナーゼ抑制剤の世界市場について調査・分析し、ガン・ヤヌス・キナーゼ抑制剤のメーカー別販売量、市場シェア分析、種類別販売分析(ルキソリチニブ、モメロチニブ、レスタウルチニブ、パクリチニブ)、用途別販売分析(Hospitals、Ambulatory Surgical Centers、Others)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・ガン・ヤヌス・キナーゼ抑制剤市場概要
・ガン・ヤヌス・キナーゼ抑制剤のメーカー別販売量・メーカー別シェア
・ガン・ヤヌス・キナーゼ抑制剤の種類別販売量(ルキソリチニブ、モメロチニブ、レスタウルチニブ、パクリチニブ)
・ガン・ヤヌス・キナーゼ抑制剤の用途別販売量(Hospitals、Ambulatory Surgical Centers、Others)
・ガン・ヤヌス・キナーゼ抑制剤の地域別販売量・市場シェア
・ガン・ヤヌス・キナーゼ抑制剤のアメリカ市場規模(2014年-2019年)
・ガン・ヤヌス・キナーゼ抑制剤のヨーロッパ市場規模(2014年-2019年)
・ガン・ヤヌス・キナーゼ抑制剤の中国市場規模(2014年-2019年)
・ガン・ヤヌス・キナーゼ抑制剤の日本市場規模(2014年-2019年)
・ガン・ヤヌス・キナーゼ抑制剤の東南アジア市場規模(2014年-2019年)
・ガン・ヤヌス・キナーゼ抑制剤のインド市場規模(2014年-2019年)
・ガン・ヤヌス・キナーゼ抑制剤メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・ガン・ヤヌス・キナーゼ抑制剤のコスト分析
・ガン・ヤヌス・キナーゼ抑制剤販売チャネル、流通業者、顧客
・ガン・ヤヌス・キナーゼ抑制剤の世界市場動向・機会・成長要因・課題
・ガン・ヤヌス・キナーゼ抑制剤の種類別世界市場予測(ルキソリチニブ、モメロチニブ、レスタウルチニブ、パクリチニブ)
・ガン・ヤヌス・キナーゼ抑制剤の用途別世界市場予測(Hospitals、Ambulatory Surgical Centers、Others)
・ガン・ヤヌス・キナーゼ抑制剤のアメリカ市場予測(2019年-2025年)
・ガン・ヤヌス・キナーゼ抑制剤のヨーロッパ市場予測(2019年-2025年)
・ガン・ヤヌス・キナーゼ抑制剤の中国市場予測(2019年-2025年)
・ガン・ヤヌス・キナーゼ抑制剤の日本市場予測(2019年-2025年)
・ガン・ヤヌス・キナーゼ抑制剤の東南アジア市場予測(2019年-2025年)
・ガン・ヤヌス・キナーゼ抑制剤のインド市場予測(2019年-2025年)
...
【レポートの概要】

Cancer Janus Kinase InhibitorsThe conventional modes of cancer management including surgery, radiotherapy and chemotherapy were discarded as an aspirant for the future of cancer management long back ago. The arrival of modern cancer treatment modalities like immunotherapy and targeted therapy revolutionized the outlook of the future of cancer management. Amongst both of the modern therapies, targeted therapies have shown an impressive growth in a very short duration of time. The targeted therapies developed rapidly and gained much importance in the global market for cancer therapeutics due to their advantages over the conventional therapies. Targeted therapies are safer and more efficient approach for managing cancer. The only drawback for targeted therapies was that only a few targets were available for developing cancer therapeutics. The high efficacy of targeted therapeutics for cancer raised the demand for identifying new targets.

The global Cancer Janus Kinase Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Cancer Janus Kinase Inhibitors market status and forecast, categorizes the global Cancer Janus Kinase Inhibitors market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Abbott Laboratories
Asana Biosciences
Astra Zeneca
Celon Pharmaceuticals
Dynamic Pharma
Eli Lilly
Gilead Sciences
Hanmi Pharmaceuticals
Incyte
Kyowa Hakko
Moleculin
Pfizer
PIQUR Therapeutics
Portola Pharmaceuticals
S-BIO

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Ruxolitinib
Momelotinib
Lestaurtinib
Pacritinib

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

【レポートの目次】

Table of Contents

Global Cancer Janus Kinase Inhibitors Sales Market Report 2019
1 Cancer Janus Kinase Inhibitors Market Overview
1.1 Cancer Janus Kinase InhibitorsProduct Overview
1.2 Cancer Janus Kinase Inhibitors Segment by Type
1.2.1 Global Cancer Janus Kinase Inhibitors Sales Comparison by Types (2014-2025)
1.2.2 Ruxolitinib
1.2.3 Momelotinib
1.2.4 Lestaurtinib
1.2.5 Pacritinib
1.3 Cancer Janus Kinase Inhibitors Segment by Application
1.3.1 Global Cancer Janus Kinase Inhibitors Sales Comparison by Application (2014-2025)
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Others
1.4 Cancer Janus Kinase Inhibitors Market by Region
1.4.1 Global Cancer Janus Kinase Inhibitors Revenue Comparison by Region (2014-2025)
1.4.2 United States Cancer Janus Kinase Inhibitors Status and Prospect (2014-2025)
1.4.3 Europe Cancer Janus Kinase Inhibitors Status and Prospect (2014-2025)
1.4.4 China Cancer Janus Kinase Inhibitors Status and Prospect (2014-2025)
1.4.5 Japan Cancer Janus Kinase Inhibitors Status and Prospect (2014-2025)
1.4.6 Southeast Asia Cancer Janus Kinase Inhibitors Status and Prospect (2014-2025)
1.4.7 India Cancer Janus Kinase Inhibitors Status and Prospect (2014-2025)
1.5 Global Cancer Janus Kinase Inhibitors Sales and Revenue (2014-2025)
1.5.1 Global Cancer Janus Kinase Inhibitors Sales and Growth Rate (2014-2025)
1.5.2 Global Cancer Janus Kinase Inhibitors Revenue and Growth Rate (2014-2025)

2 Cancer Janus Kinase Inhibitors by Company, Region, Type and Application
2.1 Global Cancer Janus Kinase Inhibitors Market Competition by Companies
2.1.1 Global Cancer Janus Kinase Inhibitors Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Cancer Janus Kinase Inhibitors Revenue Market Share by Company (2014-2019)
2.2 Global Cancer Janus Kinase Inhibitors Sales and Revenue by Region
2.2.1 Global Cancer Janus Kinase Inhibitors Sales Market Share by Region (2014-2019)
2.2.2 Global Cancer Janus Kinase Inhibitors Revenue Market Share by Region (2014-2019)
2.3 Global Cancer Janus Kinase Inhibitors Sales and Revenue by Type
2.3.1 Global Cancer Janus Kinase Inhibitors Sales Market Share by Type (2014-2019)
2.3.2 Global Cancer Janus Kinase Inhibitors Revenue Market Share by Type (2014-2019)
2.4 Global Cancer Janus Kinase Inhibitors Sales by Application

3 United States Cancer Janus Kinase Inhibitors Sales, Revenue and Price
3.1 United States Cancer Janus Kinase Inhibitors Sales and Revenue (2014-2019)
3.1.1 United States Cancer Janus Kinase Inhibitors Sales Growth Rate (2014-2019)
3.1.2 United States Cancer Janus Kinase Inhibitors Revenue Growth Rate (2014-2019)
3.1.3 United States Cancer Janus Kinase Inhibitors Price Trend (2014-2019)
3.2 United States Cancer Janus Kinase Inhibitors Sales Market Share by Company
3.3 United States Cancer Janus Kinase Inhibitors Sales Market Share by Type
3.4 United States Cancer Janus Kinase Inhibitors Sales Market Share by Application

4 Europe Cancer Janus Kinase Inhibitors Sales, Revenue and Price
4.1 Europe Cancer Janus Kinase Inhibitors Sales and Value (2014-2019)
4.1.1 Europe Cancer Janus Kinase Inhibitors Sales Growth Rate (2014-2019)
4.1.2 Europe Cancer Janus Kinase Inhibitors Revenue Growth Rate (2014-2019)
4.1.3 Europe Cancer Janus Kinase Inhibitors Price Trend (2014-2019)
4.2 Europe Cancer Janus Kinase Inhibitors Sales Market Share by Company
4.3 Europe Cancer Janus Kinase Inhibitors Sales Market Share by Type
4.4 Europe Cancer Janus Kinase Inhibitors Sales Market Share by Application

5 China Cancer Janus Kinase Inhibitors Sales, Revenue and Price
5.1 China Cancer Janus Kinase Inhibitors Sales and Revenue (2014-2019)
5.1.1 China Cancer Janus Kinase Inhibitors Sales Growth Rate (2014-2019)
5.1.2 China Cancer Janus Kinase Inhibitors Revenue Growth Rate (2014-2019)
5.1.3 China Cancer Janus Kinase Inhibitors Price Trend (2014-2019)
5.2 China Cancer Janus Kinase Inhibitors Sales Market Share by Company
5.3 China Cancer Janus Kinase Inhibitors Sales Market Share by Type
5.4 China Cancer Janus Kinase Inhibitors Sales Market Share by Application

6 Japan Cancer Janus Kinase Inhibitors Sales, Revenue and Price
6.1 Japan Cancer Janus Kinase Inhibitors Sales and Value (2014-2019)
6.1.1 Japan Cancer Janus Kinase Inhibitors Sales Growth Rate (2014-2019)
6.1.2 Japan Cancer Janus Kinase Inhibitors Revenue Growth Rate (2014-2019)
6.1.3 Japan Cancer Janus Kinase Inhibitors Price Trend (2014-2019)
6.2 Japan Cancer Janus Kinase Inhibitors Sales Market Share by Company
6.3 Japan Cancer Janus Kinase Inhibitors Sales Market Share by Type
6.4 Japan Cancer Janus Kinase Inhibitors Sales Market Share by Application

7 Southeast Asia Cancer Janus Kinase Inhibitors Sales, Revenue and Price
7.1 Southeast Asia Cancer Janus Kinase Inhibitors Sales and Value (2014-2019)
7.1.1 Southeast Asia Cancer Janus Kinase Inhibitors Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Cancer Janus Kinase Inhibitors Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Cancer Janus Kinase Inhibitors Price Trend (2014-2019)
7.2 Southeast Asia Cancer Janus Kinase Inhibitors Sales Market Share by Company
7.3 Southeast Asia Cancer Janus Kinase Inhibitors Sales Market Share by Type
7.4 Southeast Asia Cancer Janus Kinase Inhibitors Sales Market Share by Application

8 India Cancer Janus Kinase Inhibitors Sales, Revenue and Price
8.1 India Cancer Janus Kinase Inhibitors Sales and Value (2014-2019)
8.1.1 India Cancer Janus Kinase Inhibitors Sales Growth Rate (2014-2019)
8.1.2 India Cancer Janus Kinase Inhibitors Revenue Growth Rate (2014-2019)
8.1.3 India Cancer Janus Kinase Inhibitors Price Trend (2014-2019)
8.2 India Cancer Janus Kinase Inhibitors Sales Market Share by Company
8.3 India Cancer Janus Kinase Inhibitors Sales Market Share by Type
8.4 India Cancer Janus Kinase Inhibitors Sales Market Share by Application

9 Company Profiles and Key Figures in Cancer Janus Kinase Inhibitors Business
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.1.2 Cancer Janus Kinase Inhibitors Specification and Application
9.1.3 Abbott Laboratories Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Asana Biosciences
9.2.1 Asana Biosciences Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.2.2 Cancer Janus Kinase Inhibitors Specification and Application
9.2.3 Asana Biosciences Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Astra Zeneca
9.3.1 Astra Zeneca Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.3.2 Cancer Janus Kinase Inhibitors Specification and Application
9.3.3 Astra Zeneca Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Celon Pharmaceuticals
9.4.1 Celon Pharmaceuticals Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.4.2 Cancer Janus Kinase Inhibitors Specification and Application
9.4.3 Celon Pharmaceuticals Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Dynamic Pharma
9.5.1 Dynamic Pharma Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.5.2 Cancer Janus Kinase Inhibitors Specification and Application
9.5.3 Dynamic Pharma Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Eli Lilly
9.6.1 Eli Lilly Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.6.2 Cancer Janus Kinase Inhibitors Specification and Application
9.6.3 Eli Lilly Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Gilead Sciences
9.7.1 Gilead Sciences Production Sites and Area Served
9.7.2 Cancer Janus Kinase Inhibitors Specification and Application
9.7.3 Gilead Sciences Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Hanmi Pharmaceuticals
9.8.1 Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.8.2 Cancer Janus Kinase Inhibitors Specification and Application
9.8.3 Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Incyte
9.9.1 Incyte Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.9.2 Cancer Janus Kinase Inhibitors Specification and Application
9.9.3 Incyte Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served
9.10 Kyowa Hakko
9.10.1 Kyowa Hakko Cancer Janus Kinase Inhibitors Production Sites and Area Served
9.10.2 Cancer Janus Kinase Inhibitors Specification and Application
9.10.3 Kyowa Hakko Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business and Markets Served
9.11 Moleculin
9.12 Pfizer
9.13 PIQUR Therapeutics
9.14 Portola Pharmaceuticals
9.15 S-BIO

10 Cancer Janus Kinase Inhibitors Maufacturing Cost Analysis
10.1 Cancer Janus Kinase Inhibitors Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Cancer Janus Kinase Inhibitors
10.4 Cancer Janus Kinase Inhibitors Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Cancer Janus Kinase Inhibitors Distributors List
11.3 Cancer Janus Kinase Inhibitors Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Cancer Janus Kinase Inhibitors Market Forecast
13.1 Global Cancer Janus Kinase Inhibitors Sales, Revenue and Price Forecast
13.1.1 Global Cancer Janus Kinase Inhibitors Sales Growth Forecast (2019-2025)
13.1.2 Global Cancer Janus Kinase Inhibitors Revenue Growth Forecast (2019-2025)
13.1.3 Global Cancer Janus Kinase Inhibitors Price Trend Forecast (2019-2025)
13.2 Global Cancer Janus Kinase Inhibitors Forecast by Region
13.2.1 Global Cancer Janus Kinase Inhibitors Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Cancer Janus Kinase Inhibitors Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Cancer Janus Kinase Inhibitors Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Cancer Janus Kinase Inhibitors Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Cancer Janus Kinase Inhibitors Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Cancer Janus Kinase Inhibitors Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Cancer Janus Kinase Inhibitors Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Cancer Janus Kinase Inhibitors Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Cancer Janus Kinase Inhibitors Forecast by Type
13.3.1 Global Cancer Janus Kinase Inhibitors Sales Forecast by Type (2019-2025)
13.3.2 Global Cancer Janus Kinase Inhibitors Revenue Forecast by Type (2019-2025)
13.3.3 Global Cancer Janus Kinase Inhibitors Price Forecast by Type (2019-2025)
13.4 Global Cancer Janus Kinase Inhibitors Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のガン・ヤヌス・キナーゼ抑制剤市場:販売動向2019(Global Cancer Janus Kinase Inhibitors Sales Market Report 2019)]についてメールでお問い合わせはこちらでお願いします。